Related Experiment Video
Updated: May 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Malignant induction probability maps for radiotherapy using X-ray and proton beams.
1Particle Therapy Cancer Research Institute, Denys Wilkinson Building, Oxford, UK. Claire.Timlin@ptcri.ox.ac.uk
This study visualizes cancer induction risk in radiotherapy. For proton therapy, increasing fields can raise risk, but protons offer lower risk for superficial tumors. Minimizing irradiated tissue volume is key to reducing overall risk.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Biology
Background:
- Radiotherapy planning requires precise dose distribution visualization.
- Assessing the risk of secondary cancer induction is crucial for long-term patient outcomes.
- Current methods often lack integrated visualization of dose and cancer risk.
Purpose of the Study:
- To develop and display Malignant Induction Probability (MIP) maps alongside dose distributions for X-ray and proton therapy.
- To model cancer induction risk based on dose, fractionation, and relative biological effectiveness.
- To explore the influence of treatment geometry on MIP.
Main Methods:
- Utilized a linear quadratic model to calculate MIP, incorporating dose, fractionation, cell killing, and cancer induction.
- Developed an interactive MATLAB program for visualizing dose distributions and MIP maps.
- Modeled two scenarios: central tumor and superficial tumor, with varying treatment field options.
Main Results:
- Proton therapy's MIP increases with the number of treatment fields, potentially exceeding X-ray MIP in some configurations.
- Protons demonstrate lower MIPs for superficial targets due to the absence of exit dose.
- A 'dose bath' significantly increases MIP (up to tenfold), highlighting the impact of scattered radiation.
- MIP is influenced by treatment geometry, including beam path length and irradiated tissue volume.
Conclusions:
- Three-dimensional visualization of carcinogenesis risk is achievable.
- Reducing the volume of irradiated normal tissue is critical for minimizing total MIP.
- Findings support the use of advanced treatment gantries and simplified field arrangements in particle therapy, respecting normal tissue constraints.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021